Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
400 participants
OBSERVATIONAL
2019-09-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Primary outcome measure: LARS score before surgery and 1 year after the surgery.
* Primary comparison: Between average LARS score before and after curative surgery and also comparing these with publish LARS score on normal population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long - Term Low Anterior Resection Syndrome
NCT03920202
Validation of the French Version of the Low Anterior Resection Syndrome (LARS) Among Rectal Cancer Patients
NCT03569488
ProLARS Trial: Prospective Longitudinal Follow-up of Low Anterior Resection Syndrome (LARS) and COREFO Score After Rectum Surgery in Patients Undergoing Upfront Surgery or Different Neo-adjuvant Treatment Regimens
NCT07339904
Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life
NCT06059170
Italian Validation of the LARS Score
NCT04406311
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patients undergoing low anterior resection
Patients before the surgery and one year after the surgery will be assessed with questionnaire.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective surgery patients.
* Laparoscopic, laparoscopic-converted, robotic, TaTME (transanal total mesorectal excision) and open cases will be included.
* Patients aged 18 years and over should be included.
Exclusion Criteria
* Patients with palliative treatment.
* Patients with recurrence should be excluded.
* Patients with dementia
* Patients who do not complete their treatment within 12 months of primary surgery e.g. including reversal of stoma, chemotherapy etc
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King's College London
OTHER
National Cancer Institute (NCI)
NIH
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Audrius Dulskas
Assoc. professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph Nunoo-Mensah, MD
Role: STUDY_DIRECTOR
King's College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cancer Institute
Vilnius, , Lithuania
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISUCRS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.